The authors raise appropriate concerns as they present evidence of a growing trend toward early endoscopic injection in a large, privately insured North American pediatric population. Regardless of the well acknowledged limitations, this report provides a glimpse at treatment patterns in the United States following approval of Dx/HA. Although the generalizability of the findings is limited, it is unlikely that they represent an isolated phenomenon.
展开▼
